Table 2.

Association analyses between the expression levels of ΔNp73 and TAp73α and the clinical characteristics of cervical SCC patients

CharacteristicsTotalΔNp73 expression
TAp73α expression
≤50%>50%P≤50%>50%P
All cases11769 (59.0%)48 (41.0%)81(69.2%)36 (30.8%)
Age (y)
    <556041 (59.4%)19 (39.6%)40 (49.4%)20 (55.6%)
    ≥555728 (40.6%)29 (60.4%)0.02741 (50.6%)16 (44.4%)0.339
Stage
    Early7850 (72.5%)28 (58.3%)55 (67.9%)23 (63.9%)
    Late3919 (27.5%)20 (41.7%)0.08226 (32.1%)13 (36.1%)0.413
Radiosensitivity
    Sensitive3327 (81.8%)6 (18.2%)8 (24.2%)25 (75.8%)
    Resistant5115 (29.4%)36 (70.6%)<0.00148 (94.1%)3 (5.9%)<0.001
Recurrence
    −9362 (66.7%)31 (33.3%)61 (65.6%)32 (34.4%)
    +247 (29.2%)17 (70.8%)0.00120 (83.3%)4 (16.7%)0.136